# Makoto Naruke

> Makoto Naruke is a seed investor in Sapporo backing Apps, News and Medical. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Location: Sapporo, Japan
- Total investments: 4
- Last investment: Jun 2024
- Lead investor: 0%
- Last updated: Aug 2026
- Facebook: https://web.facebook.com/makoto.naruke

Makoto Naruke is a seed investor in Sapporo focused on Apps and News. Makoto Naruke

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Apps | 1 | 25% |
| News | 1 | 25% |
| Medical | 1 | 25% |
| Analytics | 1 | 25% |
| Geospatial | 1 | 25% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 25% |
| Series B | 1 | 25% |
| Series C | 1 | 25% |
| Funding Round | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Synspective | Synspective provides SAR data and remote monitoring services to government agencies. Its satellite data technology utilizes and integrates data from satellite constellations, big data, and machine learning. It provides various satellite services, including remote sensing and satellite imagery using small-sized SAR satellites that can measure humanactivity over a wide area on earth, regardless of time or weather. | $44M | Series C | Jun 20, 2024 |  |
| AutoPhagyGO | AutoPhagyGO offers autophagy solutions for the prevention and treatment of neurodegenerative diseases. Autophagy, the primary mechanism that controls lifespan, is controlled by its numerous aging-related occurrences and diseases may be preventable and treatable. The company uses the findings of the most recent autophagy research to promote healthylongevity. | $14.2M |  | May 31, 2020 |  |
| AutoPhagyGO | AutoPhagyGO offers autophagy solutions for the prevention and treatment of neurodegenerative diseases. Autophagy, the primary mechanism that controls lifespan, is controlled by its numerous aging-related occurrences and diseases may be preventable and treatable. The company uses the findings of the most recent autophagy research to promote healthylongevity. | $928.4K | Seed | May 31, 2020 |  |
| Spectee | Spectee is a online news agency that specializes in curating and publishing real-time social media UGC video. By using artificial intelligence patented by Spectee, It is able to reduce the time taken to analyze and sort social media news content, giving you faster access to the very latest UGC video. Expect video covering both Japanese andworldwide news from accidents and disasters to lifestyle and entertainment.​ it newsroom is verifying and acquiring licenses of those contents for broadcasters and publishers. | $36.9M | Series B | Oct 04, 2017 |  |

4 of 4 investments shown.

## Co-investors
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund, 3 deals together
- [Arco Partners](https://shizune.co/investors/profile/arco-partners) — VC Fund, 1 deal together
- [aSTART](https://shizune.co/investors/profile/%EF%BD%81start) — VC Fund, 1 deal together
- [DaiwaHouse](https://shizune.co/investors/profile/daiwahouse) — VC Fund, 1 deal together
- [JAFCO](https://shizune.co/investors/profile/jafco-co-ltd) — VC Fund, 1 deal together
- [Japan Growth Capital Investment Corp.](https://shizune.co/investors/profile/japan-growth-capital-investment-corp) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Medical Angel Investors in Japan](https://shizune.co/investors/medical-angel-investors-japan)

## FAQ

### What does Makoto Naruke invest in?

Makoto Naruke invests primarily in Apps, News and Medical startups, most often at Seed and Series B stage. Most of the 4 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Makoto Naruke last invest?

The most recent investment recorded for Makoto Naruke closed in Jun 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co